Stock Market News
U.S. FDA authorizes COVID vaccines for youngest children
2022.06.17 16:11
FILE PHOTO: A child is administered a dose of the Pfizer-BioNTech coronavirus disease (COVID-19) pediatric vaccine, in San Jose, Costa Rica February 23, 2022. REUTERS/Mayela Lopez
X (Reuters) – The U.S. Food and Drug Administration on Friday authorized two COVID-19 vaccines for millions of the youngest American children.
The agency authorized Moderna (NASDAQ:MRNA) Inc’s shot for children aged 6 months to 17 years old, and Pfizer-BioNTech’s vaccine for children aged 6 months to 4 years of age.
